Analysts expect Altria Group to report Q2 2026 revenue of $5.35 billion and EPS of $1.50, with shares trading near 52-week highs at $75.51, slightly above the consensus target of $70.78.
The primary focus for investors is the progress of Altria's smoke-free transition, specifically the retail market share growth for on! nicotine pouches and NJOY shipment performance.
Strong pricing power in the flagship Marlboro brand continues to successfully offset secular declines in domestic cigarette volumes. Management’s ability to maintain high operating margins while navigating the shift toward reduced-risk alternatives remains the central pillar for the stock’s premium 5.8% dividend yield.